NYXH has recently launched a large study called BREATHE, aimed at examining the real impact of the Genio system on patients' sleep quality. This study is considered a fundamental step towards the development and acceptance of this innovative technology in the treatment of sleep disorders.
Why is the BREATHE Study Important?
Sleep disorders are a common issue in contemporary society, significantly affecting individuals' quality of life. Given that current treatments often come with side effects, NYXH hopes to provide an effective and safe solution with the non-invasive Genio technology.
The BREATHE study is being conducted simultaneously at several reputable medical centers and includes various groups of patients. The goal of this study is to gather real evidence of Genio's impact on improving sleep and reducing symptoms associated with sleep disorders. In this regard, NYXH is examining how Genio performs in real-world conditions and comparing it with other treatment methods.
Challenges and Opportunities
Although NYXH is seeking to prove Genio's efficacy, there are many challenges along the way. One of the biggest challenges is gaining the trust of doctors and patients in this new technology. At the same time, if the BREATHE study yields positive results, it could significantly accelerate the acceptance of Genio in the sleep disorder treatment market.
On the other hand, success in this study could help NYXH be recognized as a leader in the sleep treatment industry and pave the way for further research and developments in this field. Therefore, the results of this study are highly significant not only for NYXH but for the entire medical industry.
